Publication
Current directions in regulatory and intellectual property law in Canadian pharmaceutical cases
Global | Publication | April 2016
Recent pharmaceutical cases in regulatory and intellectual property law have resulted in developments on several fronts, including:
- regulatory matters;
- patent validity and damages;
- Patented Medicines (Notice of Compliance) Regulations proceedings; and
- class actions.
In this paper, we review some of the most notable Canadian decisions from 2015 that will continue to impact the legal landscape for the pharmaceutical industry in Canada over the coming year.
Download the brochure here: 2015 Pharma in Brief (pdf 2.15MB)
Recent publications
Publication
The GCR Guide to Life Sciences – Product denigration
Marta Giner Asins and Arnaud Sanz of our Paris office are the authors of a chapter on product denigration that has been published in the third edition of the Global Competition Review’s The Guide to Life Sciences.
Publication
The GCR Guide to Life Sciences – Merger control: Procedural issues
Miranda Cole, Julien Haverals and Emma Clarke of our Brussels/ London offices are the authors of a chapter on procedural issues in merger control that has been published in the third edition of the Global Competition Review’s The Guide to Life Sciences. This covers a number of significant procedural developments that have affected merger review of life sciences transactions.
Subscribe and stay up to date with the latest legal news, information and events . . .